[HTML][HTML] Doxorubicin and other anthracyclines in cancers: Activity, chemoresistance and its overcoming

R Mattioli, A Ilari, B Colotti, L Mosca, F Fazi… - Molecular Aspects of …, 2023 - Elsevier
Anthracyclines have been important and effective treatments against a number of cancers
since their discovery. However, their use in therapy has been complicated by severe side …

Recent progress in bioconjugation strategies for liposome-mediated drug delivery

B Almeida, OK Nag, KE Rogers, JB Delehanty - Molecules, 2020 - mdpi.com
In nanoparticle (NP)-mediated drug delivery, liposomes are the most widely used drug
carrier, and the only NP system currently approved by the FDA for clinical use, owing to their …

Leveraging disulfiram to treat cancer: Mechanisms of action, delivery strategies, and treatment regimens

Y Lu, Q Pan, W Gao, Y Pu, K Luo, B He, Z Gu - Biomaterials, 2022 - Elsevier
Disulfiram (DSF) has been used as an alcoholism drug for 70 years. Recently, it has
attracted increasing attention owing to the distinguished anticancer activity, which can be …

Recent advances in repurposing disulfiram and disulfiram derivatives as copper-dependent anticancer agents

V Kannappan, M Ali, B Small, G Rajendran… - Frontiers in Molecular …, 2021 - frontiersin.org
Copper (Cu) plays a pivotal role in cancer progression by acting as a co-factor that regulates
the activity of many enzymes and structural proteins in cancer cells. Therefore, Cu-based …

Doxorubicin-loaded graphene oxide nanocomposites in cancer medicine: stimuli-responsive carriers, co-delivery and suppressing resistance

M Ashrafizadeh, H Saebfar, MH Gholami… - Expert opinion on …, 2022 - Taylor & Francis
Introduction The application of doxorubicin (DOX) in cancer therapy has been limited due to
its drug resistance and poor internalization. Graphene oxide (GO) nanostructures have the …

Nanotherapeutics approaches to overcome P-glycoprotein-mediated multi-drug resistance in cancer

J Halder, D Pradhan, B Kar, G Ghosh, G Rath - … , Biology and Medicine, 2022 - Elsevier
Multidrug resistance (MDR) in cancer chemotherapy is a growing concern for medical
practitioners. P-glycoprotein (P-gp) overexpression is one of the major reasons for multidrug …

Strategies for liposome drug delivery systems to improve tumor treatment efficacy

J Wang, J Gong, Z Wei - Aaps Pharmscitech, 2022 - Springer
In the advancement of tumor therapy, in addition to the search for new antitumor
compounds, the development of nano-drug delivery systems has opened up new pathways …

Doxorubicin nanoformulations on therapy against cancer: An overview from the last 10 years

NA D'Angelo, MA Noronha, MCC Câmara… - Biomaterials …, 2022 - Elsevier
Doxorubicin (DOX) is a natural antibiotic with antineoplastic activity. It has been used for
over 40 years and remains one of the most used drugs in chemotherapy for a variety of …

Green synthesized polyvinylpyrrolidone/titanium dioxide hydrogel nanocomposite modified with agarose macromolecules for sustained and pH-responsive release of …

M Pourmadadi, F Yazdian, A Koulivand… - International Journal of …, 2023 - Elsevier
Cancer, as one of the most challenging diseases of the last century, has a significant
number of patients and deaths every year. Various strategies have been explored for the …

[HTML][HTML] Nanomaterials in cancer: Reviewing the combination of hyperthermia and triggered chemotherapy

TP Ribeiro, JA Moreira, FJ Monteiro… - Journal of controlled …, 2022 - Elsevier
Nanoparticle mediated hyperthermia has been explored as a method to increase cancer
treatment efficacy by heating tumours inside-out. With that purpose, nanoparticles have …